Status:
UNKNOWN
Attenuation Imaging in Hepatic Steatosis
Lead Sponsor:
Hallym University Kangnam Sacred Heart Hospital
Conditions:
Hepatic Steatosis
Obesity, Childhood
Eligibility:
All Genders
5-17 years
Brief Summary
For obese and normal-weight children, the investigators assess the diagnostic performance of attenuation imaging (ATI) in the detection of hepatic steatosis in children.
Eligibility Criteria
Inclusion
- BMI of 85th percentile or less
Exclusion
- congenital anomaly including heart, intestine, kidney
- acute hepatitis
- congenital hepatic anomaly
Key Trial Info
Start Date :
April 14 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 14 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05302258
Start Date
April 14 2022
End Date
December 14 2022
Last Update
March 31 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.